Cargando…
Pharmacological Interventions for Pulmonary Involvement in Rheumatic Diseases
Among the diverse forms of lung involvement, interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) are two important conditions in patients with rheumatic diseases that are associated with significant morbidity and mortality. The management of ILD and PAH is challenging because t...
Autores principales: | Kang, Eun Ha, Song, Yeong Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999892/ https://www.ncbi.nlm.nih.gov/pubmed/33802193 http://dx.doi.org/10.3390/ph14030251 |
Ejemplares similares
-
Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment
por: Ha, You-Jung, et al.
Publicado: (2018) -
Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020) -
New pharmacological strategies in rheumatic diseases
por: Schiotis, RE, et al.
Publicado: (2016) -
Liver involvement in rheumatic diseases
por: Podgórska, Joanna, et al.
Publicado: (2020) -
Ocular involvement in rheumatic diseases
por: Dankiewicz-Fares, Iwona, et al.
Publicado: (2023)